Ligand validation:2DXI

ATP: ADENOSINE-5'-TRIPHOSPHATE

ATP is a Ligand Of Interest in 2DXI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2DXI_ATP_B_602	12%	55%	0.235	0.764	0.84	0.9	1	2	2	0	100%	1
2DXI_ATP_A_601	6%	46%	0.298	0.73	1.06	1.04	1	3	3	0	100%	1
1J09_ATP_A_501	97%	54%	0.072	0.984	0.68	1.1	-	3	0	0	100%	1
1N75_ATP_A_501	94%	52%	0.072	0.973	0.72	1.12	-	3	0	0	100%	1
1N77_ATP_B_601	11%	45%	0.287	0.801	0.66	1.44	-	7	4	0	100%	1
2CV1_ATP_B_602	10%	53%	0.245	0.746	0.85	0.96	1	3	3	0	100%	1
2PNN_ATP_A_374	100%	30%	0.027	0.995	1.34	1.43	4	5	2	0	100%	0.9774
5J1T_ATP_A_401	100%	31%	0.03	0.994	1.31	1.43	2	7	0	0	100%	1
1XDN_ATP_A_501	100%	45%	0.03	0.99	1	1.14	2	3	0	0	100%	1
3MHY_ATP_C_113	100%	53%	0.034	0.992	0.86	0.94	-	2	0	0	100%	1
8YN0_ATP_E_601	100%	30%	0.035	0.991	0.88	1.89	-	8	3	0	100%	0.93

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.